Asset Management
Compare Stocks
4 / 10Stock Comparison
NEWT vs BSVN vs FFIN vs HONE
Revenue, margins, valuation, and 5-year total return — side by side.
Banks - Regional
Banks - Regional
Banks - Regional
NEWT vs BSVN vs FFIN vs HONE — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Asset Management | Banks - Regional | Banks - Regional | Banks - Regional |
| Market Cap | $394M | $416M | $4.61B | $522M |
| Revenue (TTM) | $322M | $137M | $739M | $314M |
| Net Income (TTM) | $61M | $43M | $243M | $26M |
| Gross Margin | 75.3% | 70.2% | 70.8% | 50.9% |
| Operating Margin | 42.5% | 41.4% | 36.8% | 10.9% |
| Forward P/E | 5.9x | 9.9x | 15.9x | 13.3x |
| Total Debt | $823M | $0.00 | $197M | $517M |
| Cash & Equiv. | $284M | $245M | $763M | $231M |
NEWT vs BSVN vs FFIN vs HONE — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| NewtekOne, Inc. (NEWT) | 100 | 79.7 | -20.3% |
| Bank7 Corp. (BSVN) | 100 | 430.9 | +330.9% |
| First Financial Ban… (FFIN) | 100 | 105.7 | +5.7% |
| HarborOne Bancorp, … (HONE) | 100 | 151.8 | +51.8% |
Price return only. Dividends and distributions are not included.
Quick Verdict: NEWT vs BSVN vs FFIN vs HONE
Each card shows where this stock fits in a portfolio — not just who wins on paper.
NEWT carries the broadest edge in this set and is the clearest fit for value and dividends.
- Lower P/E (5.9x vs 15.9x), PEG 0.72 vs 3.05
- 8.0% yield, 1-year raise streak, vs FFIN's 2.2%
- +45.6% vs FFIN's -3.2%
BSVN is the #2 pick in this set and the best alternative if long-term compounding and sleep-well-at-night is your priority.
- 155.9% 10Y total return vs FFIN's 145.4%
- Lower volatility, beta 0.83, current ratio 502.78x
- PEG 0.58 vs FFIN's 3.05
- Beta 0.83, yield 2.2%, current ratio 502.78x
FFIN is the clearest fit if your priority is growth.
- 18.8% NII/revenue growth vs BSVN's -3.9%
HONE is the clearest fit if your priority is income & stability and growth exposure.
- Dividend streak 5 yrs, beta 1.05, yield 2.6%
- Rev growth 10.7%, EPS growth 78.4%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 18.8% NII/revenue growth vs BSVN's -3.9% | |
| Value | Lower P/E (5.9x vs 15.9x), PEG 0.72 vs 3.05 | |
| Quality / Margins | Efficiency ratio 0.3% vs HONE's 0.4% (lower = leaner) | |
| Stability / Safety | Beta 0.83 vs NEWT's 1.69 | |
| Dividends | 8.0% yield, 1-year raise streak, vs FFIN's 2.2% | |
| Momentum (1Y) | +45.6% vs FFIN's -3.2% | |
| Efficiency (ROA) | Efficiency ratio 0.3% vs HONE's 0.4% |
NEWT vs BSVN vs FFIN vs HONE — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
Segment breakdown not available.
Segment breakdown not available.
NEWT vs BSVN vs FFIN vs HONE — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
NEWT leads in 2 of 6 categories
FFIN leads 1 • BSVN leads 1 • HONE leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
NEWT leads this category, winning 3 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
FFIN is the larger business by revenue, generating $739M annually — 5.4x BSVN's $137M. BSVN is the more profitable business, keeping 31.4% of every revenue dollar as net income compared to HONE's 8.7%.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $322M | $137M | $739M | $314M |
| EBITDAEarnings before interest/tax | $96M | $58M | $310M | $37M |
| Net IncomeAfter-tax profit | $61M | $43M | $243M | $26M |
| Free Cash FlowCash after capex | -$405M | $36M | $290M | $46M |
| Gross MarginGross profit ÷ Revenue | +75.3% | +70.2% | +70.8% | +50.9% |
| Operating MarginEBIT ÷ Revenue | +42.5% | +41.4% | +36.8% | +10.9% |
| Net MarginNet income ÷ Revenue | +18.8% | +31.4% | +30.2% | +8.7% |
| FCF MarginFCF ÷ Revenue | +17.3% | +33.6% | +39.6% | +0.8% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | — | — | — |
| EPS Growth (YoY)Latest quarter vs prior year | +11.8% | -3.4% | -7.7% | +11.1% |
Valuation Metrics
NEWT leads this category, winning 4 of 7 comparable metrics.
Valuation Metrics
At 5.8x trailing earnings, NEWT trades at a 72% valuation discount to FFIN's 20.8x P/E. Adjusting for growth (PEG ratio), BSVN offers better value at 0.57x vs FFIN's 3.98x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $394M | $416M | $4.6B | $522M |
| Enterprise ValueMkt cap + debt − cash | $933M | $171M | $4.0B | $808M |
| Trailing P/EPrice ÷ TTM EPS | 5.79x | 9.77x | 20.76x | 18.33x |
| Forward P/EPrice ÷ next-FY EPS est. | 5.93x | 9.89x | 15.92x | 13.30x |
| PEG RatioP/E ÷ EPS growth rate | 0.70x | 0.57x | 3.98x | 1.23x |
| EV / EBITDAEnterprise value multiple | 6.79x | 2.95x | 14.17x | 20.84x |
| Price / SalesMarket cap ÷ Revenue | 1.22x | 3.03x | 6.23x | 1.66x |
| Price / BookPrice ÷ Book value/share | 0.88x | 1.68x | 2.89x | 0.87x |
| Price / FCFMarket cap ÷ FCF | 7.05x | 9.01x | 15.73x | 200.70x |
Profitability & Efficiency
FFIN leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
BSVN delivers a 18.2% return on equity — every $100 of shareholder capital generates $18 in annual profit, vs $5 for HONE. FFIN carries lower financial leverage with a 0.12x debt-to-equity ratio, signaling a more conservative balance sheet compared to NEWT's 2.07x. On the Piotroski fundamental quality scale (0–9), FFIN scores 6/9 vs NEWT's 4/9, reflecting solid financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | +17.3% | +18.2% | +13.3% | +4.6% |
| ROA (TTM)Return on assets | +2.6% | +2.3% | +1.6% | +0.5% |
| ROICReturn on invested capital | +9.2% | +18.3% | +11.0% | +2.3% |
| ROCEReturn on capital employed | +13.6% | +5.2% | +16.0% | +3.5% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 5 | 6 | 6 |
| Debt / EquityFinancial leverage | 2.07x | — | 0.12x | 0.90x |
| Net DebtTotal debt minus cash | $539M | -$245M | -$566M | $285M |
| Cash & Equiv.Liquid assets | $284M | $245M | $763M | $231M |
| Total DebtShort + long-term debt | $823M | $0 | $197M | $517M |
| Interest CoverageEBIT ÷ Interest expense | 1.10x | 1.39x | 1.48x | 0.24x |
Total Returns (Dividends Reinvested)
BSVN leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in BSVN five years ago would be worth $27,837 today (with dividends reinvested), compared to $7,178 for FFIN. Over the past 12 months, NEWT leads with a +45.6% total return vs FFIN's -3.2%. The 3-year compound annual growth rate (CAGR) favors BSVN at 25.5% vs FFIN's 8.9% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | +21.3% | +6.9% | +8.5% | — |
| 1-Year ReturnPast 12 months | +45.6% | +22.0% | -3.2% | +7.9% |
| 3-Year ReturnCumulative with dividends | +35.4% | +97.5% | +29.1% | +58.9% |
| 5-Year ReturnCumulative with dividends | -23.2% | +178.4% | -28.2% | -5.8% |
| 10-Year ReturnCumulative with dividends | +142.9% | +155.9% | +145.4% | +88.3% |
| CAGR (3Y)Annualised 3-year return | +10.6% | +25.5% | +8.9% | +16.7% |
Risk & Volatility
Evenly matched — NEWT and BSVN each lead in 1 of 2 comparable metrics.
Risk & Volatility
BSVN is the less volatile stock with a 0.83 beta — it tends to amplify market swings less than NEWT's 1.69 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. NEWT currently trades 91.7% from its 52-week high vs FFIN's 83.6% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.69x | 0.83x | 0.95x | 1.05x |
| 52-Week HighHighest price in past year | $14.91 | $50.10 | $38.74 | $14.29 |
| 52-Week LowLowest price in past year | $9.59 | $36.47 | $28.11 | $10.57 |
| % of 52W HighCurrent price vs 52-week peak | +91.7% | +87.7% | +83.6% | +84.7% |
| RSI (14)Momentum oscillator 0–100 | 63.8 | 55.1 | 58.2 | 32.5 |
| Avg Volume (50D)Average daily shares traded | 205K | 11K | 740K | 0 |
Analyst Outlook
Evenly matched — NEWT and FFIN each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: NEWT as "Hold", BSVN as "Buy", FFIN as "Hold", HONE as "Hold". Consensus price targets imply 29.7% upside for BSVN (target: $57) vs 2.4% for NEWT (target: $14). For income investors, NEWT offers the higher dividend yield at 8.00% vs FFIN's 2.22%.
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Buy | Hold | Hold |
| Price TargetConsensus 12-month target | $14.00 | $57.00 | $39.25 | $14.00 |
| # AnalystsCovering analysts | 9 | 3 | 15 | 6 |
| Dividend YieldAnnual dividend ÷ price | +8.0% | +2.2% | +2.2% | +2.6% |
| Dividend StreakConsecutive years of raises | 1 | 4 | 11 | 5 |
| Dividend / ShareAnnual DPS | $1.09 | $0.98 | $0.72 | $0.32 |
| Buyback YieldShare repurchases ÷ mkt cap | +0.4% | +0.3% | 0.0% | +4.1% |
NEWT leads in 2 of 6 categories (Income & Cash Flow, Valuation Metrics). FFIN leads in 1 (Profitability & Efficiency). 2 tied.
NEWT vs BSVN vs FFIN vs HONE: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is NEWT or BSVN or FFIN or HONE a better buy right now?
For growth investors, First Financial Bankshares, Inc.
(FFIN) is the stronger pick with 18. 8% revenue growth year-over-year, versus -3. 9% for Bank7 Corp. (BSVN). NewtekOne, Inc. (NEWT) offers the better valuation at 5. 8x trailing P/E (5. 9x forward), making it the more compelling value choice. Analysts rate Bank7 Corp. (BSVN) a "Buy" — based on 3 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — NEWT or BSVN or FFIN or HONE?
On trailing P/E, NewtekOne, Inc.
(NEWT) is the cheapest at 5. 8x versus First Financial Bankshares, Inc. at 20. 8x. On forward P/E, NewtekOne, Inc. is actually cheaper at 5. 9x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Bank7 Corp. wins at 0. 58x versus First Financial Bankshares, Inc. 's 3. 05x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — NEWT or BSVN or FFIN or HONE?
Over the past 5 years, Bank7 Corp.
(BSVN) delivered a total return of +178. 4%, compared to -28. 2% for First Financial Bankshares, Inc. (FFIN). Over 10 years, the gap is even starker: BSVN returned +155. 9% versus HONE's +88. 3%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — NEWT or BSVN or FFIN or HONE?
By beta (market sensitivity over 5 years), Bank7 Corp.
(BSVN) is the lower-risk stock at 0. 83β versus NewtekOne, Inc. 's 1. 69β — meaning NEWT is approximately 104% more volatile than BSVN relative to the S&P 500. On balance sheet safety, First Financial Bankshares, Inc. (FFIN) carries a lower debt/equity ratio of 12% versus 2% for NewtekOne, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — NEWT or BSVN or FFIN or HONE?
By revenue growth (latest reported year), First Financial Bankshares, Inc.
(FFIN) is pulling ahead at 18. 8% versus -3. 9% for Bank7 Corp. (BSVN). On earnings-per-share growth, the picture is similar: HarborOne Bancorp, Inc. grew EPS 78. 4% year-over-year, compared to -7. 0% for Bank7 Corp.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — NEWT or BSVN or FFIN or HONE?
Bank7 Corp.
(BSVN) is the more profitable company, earning 31. 4% net margin versus 8. 7% for HarborOne Bancorp, Inc. — meaning it keeps 31. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: NEWT leads at 42. 5% versus 10. 9% for HONE. At the gross margin level — before operating expenses — NEWT leads at 75. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is NEWT or BSVN or FFIN or HONE more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Bank7 Corp. (BSVN) is the more undervalued stock at a PEG of 0. 58x versus First Financial Bankshares, Inc. 's 3. 05x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, NewtekOne, Inc. (NEWT) trades at 5. 9x forward P/E versus 15. 9x for First Financial Bankshares, Inc. — 10. 0x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for BSVN: 29. 7% to $57. 00.
08Which pays a better dividend — NEWT or BSVN or FFIN or HONE?
All stocks in this comparison pay dividends.
NewtekOne, Inc. (NEWT) offers the highest yield at 8. 0%, versus 2. 2% for First Financial Bankshares, Inc. (FFIN).
09Is NEWT or BSVN or FFIN or HONE better for a retirement portfolio?
For long-horizon retirement investors, Bank7 Corp.
(BSVN) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 83), 2. 2% yield, +155. 9% 10Y return). NewtekOne, Inc. (NEWT) carries a higher beta of 1. 69 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (BSVN: +155. 9%, NEWT: +142. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between NEWT and BSVN and FFIN and HONE?
Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: NEWT is a small-cap deep-value stock; BSVN is a small-cap deep-value stock; FFIN is a small-cap high-growth stock; HONE is a small-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.